Company / Return on Assets (ROA)
Dare Bioscience, Inc. Return on Assets (ROA) History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-12.5%
FY2025
5-year range
-145.4% / -12.5%
FY2021-FY2025
Trend
+90.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -145.4% to -12.5% over the past 2 years.
Based on SEC 10-K filings.
-12.5% in FY2025 with a 10-year CAGR of +9.4%.
Improved from -145.4% to -12.5% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +75.8pp
- 5-Year Change
- -
- 10-Year Change
- +9.4pp
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 90.9% year-over-year.
- Lowest return on assets (roa) in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -2.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -12.5% | +90.9% |
| FY2024 | -136.5% | +6.2% |
| FY2023 | -145.4% | -64.7% |
| FY2022 | -88.3% | -195.9% |
| FY2016 | -29.8% | -36.2% |
| FY2015 | -21.9% | +47.1% |
| FY2014 | -41.4% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026